missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Promega ADCC Bioassay Effector Cells, F Variant, Propagation Model 
Allows propagation and banking of the ADCC Bioassay, F Variant, Effector Cells without the complex workflow and variability inherent in primary cell-based assays. The bioassay also can be used to quantify effects of antibody glycosylation on Fc effector function.
Supplier: Promega G9302
Description
- Easily quantitate impact of FcγRIIa polymorphism on Fc effector function
- Measure antibody potency and stability
- Includes two vials of Bio-Glo™ Luciferase Assay System reagent at 2x107 cells/mL and 0.65mL/vial, for creating a cell bank and as a backup
Greener Choice Claims
- Environmental benefits include:
- Renewable Energy
Specifications
| Store below -140°C (freezer or liquid nitrogen vapor phase) | |
| 2 x 1 mL | |
| Allows propagation and banking of the ADCC Bioassay, F Variant, Effector Cells | |
| ADCC Bioassay Effector Cells, F Variant (CPM) |